BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11072161)

  • 1. Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy.
    Grabenbauer GG; Mühlfriedel C; Rödel F; Niedobitek G; Hornung J; Rödel C; Martus P; Iro H; Kirchner T; Steininger H; Sauer R; Weidenbecher M; Distel L
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1041-50. PubMed ID: 11072161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalance between proliferation and apoptosis may be responsible for treatment failure after postoperative radiotherapy in squamous cell carcinoma of the oropharynx.
    Grabenbauer GG; Suckorada O; Niedobitek G; Rödel F; Iro H; Sauer R; Rödel C; Schultze-Mosgau S; Distel L
    Oral Oncol; 2003 Jul; 39(5):459-69. PubMed ID: 12747970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing?
    Levendag P; Nijdam W; Noever I; Schmitz P; van de Pol M; Sipkema D; Braat C; de Boer M; Jansen P
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):713-24. PubMed ID: 15183475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity].
    Sittel C; Ruiz S; Kvasnicka HM; Volling P; Jungehülsing M; Eckel HE
    Laryngorhinootologie; 2000 Feb; 79(2):86-92. PubMed ID: 10738715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery.
    Stapleton AM; Zbell P; Kattan MW; Yang G; Wheeler TM; Scardino PT; Thompson TC
    Cancer; 1998 Jan; 82(1):168-75. PubMed ID: 9428494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Base-of-tongue carcinoma: treatment results using concomitant boost radiotherapy.
    Mak AC; Morrison WH; Garden AS; Ang KK; Goepfert H; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):289-96. PubMed ID: 7673016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of the combination of external radiotherapy and curietherapy in carcinoma of the velo-tonsillar region. Statistical study of a series of 361 patients].
    Pernot M; Hoffstetter S; Malissard L; Luporsi E; Peiffert D; Aletti P; Marchal C; Kozminski P; Bey P
    Bull Cancer Radiother; 1996; 83(1):40-6. PubMed ID: 8679280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
    Sittel C; Ruiz S; Volling P; Kvasnicka HM; Jungehülsing M; Eckel HE
    Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma.
    Couture C; Raybaud-Diogène H; Têtu B; Bairati I; Murry D; Allard J; Fortin A
    Cancer; 2002 Feb; 94(3):713-22. PubMed ID: 11857304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
    Raybaud-Diogène H; Fortin A; Morency R; Roy J; Monteil RA; Têtu B
    J Clin Oncol; 1997 Mar; 15(3):1030-8. PubMed ID: 9060543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Place of iridium 192 implantation in irradiation of T1-T2 squamous cell carcinoma of the velopharyngeal arch].
    Mazeron JJ; Belkacemi Y; Simon JM; Le Péchoux C; Martin M; Haddad E; Piedbois P; Calitchi E; Strunski W; Peynègre R; Le Bourgeois JP; Pierquin B
    Bull Cancer Radiother; 1996; 83(1):47-53. PubMed ID: 8679281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate.
    Levendag PC; Schmitz PI; Jansen PP; Senan S; Eijkenboom WM; Sipkema D; Meeuwis CA; Kolkman-Deurloo IK; Visser AG
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):497-506. PubMed ID: 9231672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcome.
    Perez CA; Patel MM; Chao KS; Simpson JR; Sessions D; Spector GJ; Haughey B; Lockett MA
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1077-84. PubMed ID: 9869232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa.
    Gwozdz JT; Morrison WH; Garden AS; Weber RS; Peters LJ; Ang KK
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):127-35. PubMed ID: 9300747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
    Lavertu P; Adelstein DJ; Myles J; Secic M
    Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
    Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
    Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor proliferation, p53 expression, and apoptosis in laryngeal carcinoma: relation to the results of radiotherapy.
    Lera J; Lara PC; Perez S; Cabrera JL; Santana C
    Cancer; 1998 Dec; 83(12):2493-501. PubMed ID: 9874454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma of the soft palate and anterior tonsillar pillar.
    Leemans CR; Engelbrecht WJ; Tiwari R; Devillé WL; Karim AB; van der Waal I; Snow GB
    Laryngoscope; 1994 Dec; 104(12):1477-81. PubMed ID: 7990637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in patients with soft palate squamous cell carcinoma.
    Schernberg A; Canova C; Blanchard P; Gorphe P; Breuskin I; Mirghani H; Moya-Plana A; Janot F; Bidault F; Chargari C; Bellefqih S; Ruffier A; Even C; Nguyen F; Temam S; Tao Y
    Head Neck; 2019 May; 41(5):1441-1449. PubMed ID: 30636178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.